Main > CARDIOLOGY (**) > USA. C. DiUretics>SpironoLact**



USA. C. DiUretics>SpironoLact**'s subsections
(*) USA Approval Date: 2017. 08.07
(*) USA Launch Date: 2017. 10.30
>ne Oral Suspension 25 mg/5 mL
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 03.26
TradeMark
TradeMark Web-Site

USA. C. DiUretics>SpironoLact**'s products
This section has no products